Xiaobei Mao

442 total citations
12 papers, 350 citations indexed

About

Xiaobei Mao is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Xiaobei Mao has authored 12 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Surgery. Recurrent topics in Xiaobei Mao's work include FOXO transcription factor regulation (3 papers), Circular RNAs in diseases (3 papers) and Immunotherapy and Immune Responses (2 papers). Xiaobei Mao is often cited by papers focused on FOXO transcription factor regulation (3 papers), Circular RNAs in diseases (3 papers) and Immunotherapy and Immune Responses (2 papers). Xiaobei Mao collaborates with scholars based in China. Xiaobei Mao's co-authors include Lijun Xue, Xiaoyuan Chu, Longbang Chen, Xiang Liu, Lili Ren, Kai Xu, Tao Xie, Lijun Xue, Rui Wang and Tingting Dai and has published in prestigious journals such as PLoS ONE, Oncotarget and Phytotherapy Research.

In The Last Decade

Xiaobei Mao

11 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaobei Mao China	8	232	151	112	52	37	12	350
Eva Galle Belgium	6	214 0.9×	100 0.7×	136 1.2×	44 0.8×	38 1.0×	7	413
Zhiyuan Qin China	9	321 1.4×	210 1.4×	100 0.9×	59 1.1×	32 0.9×	15	418
Xinguang Cao China	9	236 1.0×	188 1.2×	94 0.8×	80 1.5×	47 1.3×	23	369
Shouman Wang China	12	154 0.7×	111 0.7×	159 1.4×	48 0.9×	34 0.9×	29	342
K Ashihara Japan	11	200 0.9×	141 0.9×	139 1.2×	53 1.0×	37 1.0×	16	407
Guanhua Wu China	8	168 0.7×	65 0.4×	64 0.6×	30 0.6×	37 1.0×	17	255
Monica Dandapani United States	7	200 0.9×	154 1.0×	97 0.9×	22 0.4×	28 0.8×	14	396
Marko Kornmann Germany	10	179 0.8×	78 0.5×	178 1.6×	40 0.8×	70 1.9×	26	375
Tania Rossi Italy	11	208 0.9×	127 0.8×	150 1.3×	40 0.8×	16 0.4×	25	322
Dilys T.H. Leung Australia	9	177 0.8×	110 0.7×	77 0.7×	36 0.7×	28 0.8×	10	340

Countries citing papers authored by Xiaobei Mao

Since Specialization

Citations

This map shows the geographic impact of Xiaobei Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobei Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobei Mao more than expected).

Fields of papers citing papers by Xiaobei Mao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaobei Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobei Mao. The network helps show where Xiaobei Mao may publish in the future.

Co-authorship network of co-authors of Xiaobei Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaobei Mao. A scholar is included among the top collaborators of Xiaobei Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaobei Mao. Xiaobei Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Chen, Yanan, Xiaobei Mao, Yichen Xu, et al.. (2024). PTOV1‐AS1 desensitizes colorectal cancer cells to 5‐FU through depressing miR‐149‐5p to activate the positive feedback loop with Wnt/β‐catenin pathway. Phytotherapy Research. 38(3). 1313–1328. 2 indexed citations

Huang, Yadi, Linlin Ji, Jialong Zhu, et al.. (2021). Lymph node status and its impact on the prognosis of left‐sided and right‐sided colon cancer: A SEER population‐based study. Cancer Medicine. 10(23). 8708–8719. 14 indexed citations

Xue, Lijun, Xiaobei Mao, Xiaobei Liu, et al.. (2019). Activation of CD3⁺ T cells by Helicobacter pylori DNA vaccines in potential immunotherapy of gastric carcinoma. Cancer Biology & Therapy. 20(6). 866–876. 16 indexed citations

Xue, Lijun, et al.. (2017). Inhibition of CXCL12/CXCR4 axis as a potential targeted therapy of advanced gastric carcinoma. Cancer Medicine. 6(6). 1424–1436. 65 indexed citations

Xue, Lijun, Xiaobei Mao, Jian Geng, et al.. (2017). Rare Gingival Metastasis by Hepatocellular Carcinoma. Case Reports in Medicine. 2017. 1–6. 2 indexed citations

Xie, Tao, Jian Geng, Ye Wang, et al.. (2016). FOXM1 evokes 5-fluorouracil resistance in colorectal cancer depending on ABCC10. Oncotarget. 8(5). 8574–8589. 59 indexed citations

Liu, Xiang, Tao Xie, Xiaobei Mao, et al.. (2016). MicroRNA-149 Increases the Sensitivity of Colorectal Cancer Cells to 5-Fluorouracil by Targeting Forkhead Box Transcription Factor FOXM1. Cellular Physiology and Biochemistry. 39(2). 617–629. 58 indexed citations

Xu, Kai, Xiang Liu, Xiaobei Mao, et al.. (2015). MicroRNA-149 Suppresses Colorectal Cancer Cell Migration and Invasion by Directly Targeting Forkhead Box Transcription Factor FOXM1. Cellular Physiology and Biochemistry. 35(2). 499–515. 75 indexed citations

Yang, Dan, Tingting Dai, Lijun Xue, et al.. (2015). Expression of chemokine receptor CXCR7 in colorectal carcinoma and its prognostic significance.. PubMed. 8(10). 13051–8. 21 indexed citations

10.

Wang, Jingzi, Youwei Zhang, Kai Xu, et al.. (2014). Genome-Wide Screen of DNA Methylation Changes Induced by Low Dose X-Ray Radiation in Mice. PLoS ONE. 9(3). e90804–e90804. 37 indexed citations

11.

Wang, Jingzi, Xiaobei Mao, Youwei Zhang, et al.. (2014). [Genome-wide screening of CpG island methylation changes induced by low-dose X-ray radiation in mice].. PubMed. 34(2). 228–31. 1 indexed citations

12.

Xue, Lijun, et al.. (2010). Rapid Remission in Peripheral T-Cell Lymphoma of the Nasal Type by the Bortezomib plus CHOP Therapy. Case Reports in Medicine. 2010. 1–4.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact